Questions in self‐selection studies used in consumer research for nonprescription drug candidates: Limitations and recommendations

Author:

Brass Eric P.1ORCID,Bradford Russell D.2ORCID,Stone Arthur3ORCID

Affiliation:

1. Department of Medicine David Geffen School of Medicine at UCLA Los Angeles California USA

2. PEGUS Research Inc. Salt Lake City Utah USA

3. Department of Psychology University of Southern California Los Angeles California USA

Abstract

AbstractSelf‐selection studies assess participants' ability to use label information to decide if a proposed nonprescription drug is appropriate for their use. The optimal use of information from participants' responses in these trials has not been studied. Data from a self‐selection study for a progestogen‐only contraceptive pill (norgestrel 0.075 mg tablets, Opill) were analyzed. Participants (1772 evaluable participants) were provided with the proposed drug facts label and asked sequentially: (1) Given what you have read on the label and your own health history, is this product okay or not okay for you to take home today and start to use?; (2) Why or why not?; (3) Would you like to purchase Opill today to take home for your own use?; (4) Why or why not? The Per Guidance Analysis based on the US Food and Drug Administration's Guidance considered only the response to the first question as defining a selector. The Complete Analysis considered the responses to all four questions to determine a selector. The Per Guidance Analysis characterized 1597 participants as selectors, whereas the Complete Analysis identified 1180 participants as selectors. The decrease in selectors reflected participants who responded “okay” to the initial question but “no” to purchase question while providing rational explanations for their shift in responses. The results support the use of all available information when assessing a participant's intent in self‐selection studies for nonprescription drug candidates. The findings are discussed in the context of findings from the social cognitive and communication sciences.

Publisher

Wiley

Reference17 articles.

1. Changing the Status of Drugs from Prescription to Over-the-Counter Availability

2. Food and Drug Administration Guidance for Industry Self‐Selection Studies for Nonprescription Drug Products. Accessed June 29 2023.https://www.fda.gov/files/drugs/published/Self‐Selection‐Studies‐for‐Nonprescription‐Drug‐Products.pdf

3. HRA Pharma.Opill (Norgestrel 0.075 mg tablets) for Rx‐to‐OTC Switch. Accessed July 1 2023.https://www.fda.gov/media/167893/download

4. Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.

5. HRA Pharma.FDA Advisory Committee Presentation May 9 2023. Accessed July 1 2023.https://www.fda.gov/media/167980/download

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3